featured
Postoperative ctDNA Combined With Consensus Molecular Subtypes to Improve Risk Stratification in Stage III Colon Cancers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Postoperative circulating tumor DNA combined with consensus molecular subtypes can better predict outcomes in stage III colon cancers: A prospective cohort study
Eur. J. Cancer 2022 Jul 01;169(xx)198-209, Y Li, S Mo, L Zhang, X Ma, X Hu, D Huang, B Lu, C Luo, H Peng, S Cai, W Sheng, J PengFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.